SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Prevalence of Asymptomatic SARS-CoV-2 Infection

(2020) Daniel P. Oran et al.   ANNALS OF INTERNAL MEDICINE

Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020

(2020) Zacharoula Bogogiannidou et al.   Eurosurveillance

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland

(2020) Javier Perez-Saez et al.   LANCET INFECTIOUS DISEASES

How deadly is the coronavirus? Scientists are close to an answer

(2020) Smriti Mallapaty   NATURE

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

(2020) Takuya Sekine et al.   CELL

Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity.

(2020) Tyler J. Ripperger et al.   IMMUNITY

A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates

(2020) Gideon Meyerowitz-Katz et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Humoral Immune Response to SARS-CoV-2 in Iceland

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India

(2020) Anup Malani et al.   Lancet Global Health